title: Adipocytokines, neuropeptide Y and insulin resistance in overweight women with gynoid and android type of adipose tissue distribution.
abstract: The AIM of the study was to compare the levels of certain adipose tissue hormones in women with the two main morphological types of obesity - android and gynoid obesity.
  
  
  METHODS
  The study included 2 groups of age- and weight-matched women with android (n = 32) and gynoid (n = 27) type of obesity, and a group of age-matched healthy women (n = 24) with normal weight and body constitution. Leptin, resistin, tumour necrosis factor alpha (TNFalpha), neuropeptide Y (NPY), glucose and insulin were measured. HOMA index was calculated.
  
  
  RESULTS
  Leptin levels in the women with gynoid obesity did not differ significantly from those in the controls and the women with android obesity. The controls had significantly lower leptin levels compared with the android obesity women. NPY was significantly higher in the control women compared to the women with android obesity and did not differ significantly between the two groups of obese women. TNFalpha levels in all groups were very similar. Resistin did not show significant differences between all groups but tended to have the lowest levels in the controls. In the women with android obesity, insulin was significantly higher than that in the women with gynoid obesity and the controls. Insulin resistance was found in the women with android obesity only. Basal insulin and HOMA index in the women with gynoid obesity did not differ significantly from the values in the control group.
  
  
  CONCLUSIONS
  The results from this study contribute to understanding the association of adipose tissue hormones and insulin resistance in obesity. When adipose tissue is predominantly distributed in the abdominal area at similar amount and percentage of body fats, leptin production is higher and insulin resistance develops. In the gynoid type of adipose tissue predisposition, overt insulin resistance is not found, leptin levels does not differ significantly from those in the control group.
authors.affiliation: Clinic of Endocrinology and Metabolic Diseases, St. George University Hospital, Medical University, Plovdiv, Bulgaria. morbetzova@abv.bg
authors.forename: Maria M
authors.initials: MM
authors.lastname: Orbetzova
authors.forename: Daniela I
authors.initials: DI
authors.lastname: Koleva
authors.forename: Mitko D
authors.initials: MD
authors.lastname: Mitkov
authors.forename: Iliana B
authors.initials: IB
authors.lastname: Atanassova
authors.forename: Julia G
authors.initials: JG
authors.lastname: Nikolova
authors.forename: Pepa K
authors.initials: PK
authors.lastname: Atanassova
authors.forename: Gencho D
authors.initials: GD
authors.lastname: Genchev
mesh_terms: D054392:Adipokines / Q000097:blood*; D000328:Adult; D050218:Body Fat Distribution; D015992:Body Mass Index; D005260:Female; D006801:Humans; D007333:Insulin Resistance; D020738:Leptin / Q000097:blood; D009478:Neuropeptide Y / Q000097:blood*; D009765:Obesity / Q000378:metabolism* / Q000473:pathology; D052243:Resistin / Q000097:blood; D014409:Tumor Necrosis Factor-alpha / Q000097:blood; D049629:Waist-Hip Ratio
chemical_list: D054392:Adipokines; D020738:Leptin; D009478:Neuropeptide Y; D052243:Resistin; D014409:Tumor Necrosis Factor-alpha